Target intelligence / Profile preview

Phosphonopyruvate decarboxylase

Molecular classification
Enzyme, Lyase, Carboxy-lyase, Thiamine pyrophosphate (TPP)-dependent enzyme
01

Overview

Phosphonopyruvate decarboxylase is an enzyme (EC 4.1.1.82) that catalyzes a decarboxylation reaction in phosphonate biosynthesis, specifically converting 3-phosphonopyruvate to 2-phosphonoacetaldehyde and carbon dioxide[7][10][6]. It is a member of the lyase family, within the carboxy-lyase subclass, and is dependent on thiamine pyrophosphate (TPP) and metal ions such as Mg2+ for activity[1][2][3][8]. The enzyme plays a crucial role in the biosynthesis of naturally occurring organophosphonates—such as 2-aminoethylphosphonate, present in the capsular polysaccharide of *Bacteroides fragilis*[2][6][10]. While it is mechanistically and structurally well-characterized, including crystal structure details for various homologs[3][8], it is not a major therapeutic drug target, nor is it associated with direct disease roles, biomarkers, or safety concerns in clinical therapeutics as currently known. Experimentally, mechanism-based inhibitors such as phosphonodifluoropyruvate have been shown to interact with and inhibit the enzyme[5].

Other names
3-phosphonopyruvate carboxy-lyase3-phosphonopyruvate carboxy-lyase (2-phosphonoacetaldehyde-forming)EC 4.1.1.82
02

Mechanism of action

ThDP (Thiamine diphosphate or TPP)-dependent irreversible decarboxylation; inhibition by substrate analogues acting as mechanism-based inactivators

03

Biological functions

Phosphonate biosynthesisAminophosphonate metabolismCatalysis of decarboxylation of phosphonopyruvate to phosphonoacetaldehyde and carbon dioxide
04

Disease associations

Other
05

Interacting drugs

phosphonodifluoropyruvate (PnDFP) (mechanism-based inhibitor, experimental)

Beyond the preview

Go deeper on Phosphonopyruvate decarboxylase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphonopyruvate decarboxylase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call